Legal & Regulatory Issues
Modernising Asia's Drug Regulations
AI and Quantum Computing as catalysts for harmonised pharmaceutical oversight
Although Asias pharmaceutical sector produces close to half of the worlds specialty generics biologicals
The Strategic Imperative to Solve the Local Literature Monitoring Problem
The monitoring and prevention of adverse drug events which forms the core of Pharmacovigilance PV
The Future of the Pharmaceutical Industry
A scenario planning approach
The pharmaceutical industry is one of the most critical sectors in healthcare responsible for developing
ECOPHARMACOVIGILANCE
Revolutionising drug safety for a sustainable future
A new era in pharmaceuticals is dawning focusing on sustainability and environmental responsibility
Drug Development in the Technology Era
Legal Considerations for Computer-Assisted Drug Design
With the cost of developing a new pharmaceutical product currently hovering around US m to USm and taking approximately ten years from product inception to approval the pharmaceutical industry is understandably keen to identify ways to reduce these metrics
China’s New PRC Biosecurity Law
Key implications for international players
Against the background of the COVID global pandemic China fasttracked and passed last year its first national biosecurity law Biosecurity Law The law which took effect on April of this year adds another key component to Chinas overall national security
PATENTS AND EXCLUSIVITY
A US perspective
When a pharmaceutical company first develops a new drug or any device to be used for the treatment of a disease it is initially marketed under a brand name by which clinicians can recommend or prescribe the drug or any device for use by patients
